DOD. Omarov

D. Omarov

*This is an algorithmically generated author record based on publicly available information.

D. Omarov has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevention of tumors in treating fibrocystic breast diseases using Vitex agnus-castus-based herbal remedy

    by N. A. Omarbayeva, D. R. Kaidarova, D. Kh. Omarov, A. Askandirova, Kh. Keskin, A. Zh. Abdrakhmanova, S. A. Yessenkulova, T. G. Goncharova, A. K. Jakipbayeva

    Background. Oncologists notice an increasing prevalence of female reproductive system pathological conditions that lead to benign and malignant diseases of mammary glands. Fibrocystic breast diseases (FBD) occur in approximately 80 % of women of reproductive age worldwide. Currently, there is no single widely accepted treatment for FBD. The therapy mainly includes surgery and hormonal treatment. A few herbal medicines effective against FBD include Vitex agnus-castus (VAC) medications. According to many studies, the absence of timely targeted preventive therapy puts patients with FBD at risk of developing malignant tumors. FBD is a risk factor for cancer development and turns into cancer in 3–6 % of patients.Aim. To assess the effectiveness of VAC against FBD.Materials and methods. In this study, 150 women aged 40+ with FBD were randomly assigned to the treatment group (n = 78) or the controls (n = 72). The groups were similar in demographic characteristics, including age, parity, menopause, history of abortions, family history of breast cancer, and alcohol and tobacco consumption. The treatment group received two tablets of VAC extract (each containing 162 mg) daily for six months. At baseline, weeks 12 and 24, all participants were evaluated using a visual analog scale and ultrasound examination.Results. Breast pain decreased significantly in the treatment group, and the median visual analog scale scores at weeks 12 and 24 decreased significantly compared to baseline in the treatment group (89.7 % at baseline, 76.9 % at week 12, and 42.3 % at week 24) compared to the controls (66.3 % at baseline, 63.9 % at week 12 and 61.1 % at week 24). Furthermore, the breast ultrasound findings at weeks 12 and 24 revealed that regression rates in the treatment group were significantly higher than in the control arm (46.2 % vs. 6.9 % at week 12; 55.1 % vs. 8.3 % at week 24).Conclusion. VAC is effective in managing patients with FBD. VAC treatment efficacy can be evaluated using a visual analog scale and ultrasound examination. The herbal remedy VAC extract used in this treatment for patients with FBD has proven effective in preventing breast cancer.


  • GENOME-WIDE ASSOCIATION STUDY IN BREAST CANCER: A LITERATURE REVIEW

    by D. Kaidarova, N. Omarbayeva, D. Omarov, A. Abdrakhmanova, K. Smagulova, T. Goncharova

    Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information. Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan. Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease.


  • GENOME-WIDE ASSOCIATION STUDY IN BREAST CANCER: A LITERATURE REVIEW

    by D. Kaidarova, N. Omarbayeva, D. Omarov, A. Abdrakhmanova, K. Smagulova, T. Goncharova

    Relevance: Breast cancer (BC) is one of the major health problems in the Republic of Kazakhstan. Genome-wide association studies (GWAS) are used to identify genetic factors contributing to breast cancer development in Kazakhstan and worldwide. The GWAS method consistently helps to find associations between certain single nucleotide polymorphisms (SNPs) in the genome and the development of pathological conditions, including breast cancer, by identifying more than 170 genomic sites. In addition to searching for loci associated with BC, these studies have expanded our understanding of BC heritability using SNPs located in regulatory areas and identifying DNA variants associated with drug metabolism for treatment personalization purposes. The study aimed to highlight the key concepts of modern methods in genetics based on GWAS. Methods: A literature search in PubMed, Scopus, GWAS Catalog, Cochrane Database of Systematic Reviews, etc., was performed to select and analyze relevant information Results: The article describes significant GWAS studies in the field of breast cancer, describes certain genes associated with the development of the disease, identifies shortcomings, and identifies further strategies for the development of GWAS in the Republic of Kazakhstan Conclusion: The results of this study have improved our understanding of the biological mechanisms that contribute to breast cancer risk and may ultimately lead to the development of new targeted therapies for the disease